Beyond Patents and Royalties: Perception and Reality of Doing Business with the NIH.

Other

Abstract

Young, and mid size biotech companies can benefit hugely from the US National Institutes of Health (NIH), not least because of the agency's non-dilutive funding, guidance, and opportunities for collaboration. Increasingly, however, there is a fair bit of misunderstanding about what the NIH can and cannot do for a biotech entrepreneur.

Authors

Ben-Menachem, Gil; Ferguson, Steven M; Balakrishnan, Krishna;

External Links